Monashee Investment Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-90,000	Closed	-$1.19M	–	209
2019 Q2	$1.19M	Buy	+90,000	New	+$1.19M	0.31%	80